{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:36:25Z","timestamp":1790206585609,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00432-014-1873-2","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T11:37:12Z","timestamp":1415965032000},"page":"933-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients"],"prefix":"10.1007","volume":"141","author":[{"given":"Yousuke","family":"Nakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Isayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naminatsu","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunaga","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Mohri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuyo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ijichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","volume":"29","author":"EI Ager","year":"2008","unstructured":"Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29:1675\u20131684. doi: 10.1093\/carcin\/bgn171","journal-title":"Carcinogenesis"},{"key":"1873_CR2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/ajg.2012.288","volume":"107","author":"MA Anderson","year":"2012","unstructured":"Anderson MA et al (2012) Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol 107:1730\u20131739. doi: 10.1038\/ajg.2012.288","journal-title":"Am J Gastroenterol"},{"key":"1873_CR3","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1158\/0008-5472.CAN-09-0015","volume":"69","author":"A Blackford","year":"2009","unstructured":"Blackford A et al (2009) Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res 69:3681\u20133688. doi: 10.1158\/0008-5472.can-09-0015","journal-title":"Cancer Res"},{"key":"1873_CR4","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/annonc\/mdr541","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C et al (2012) Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 23:1880\u20131888. doi: 10.1093\/annonc\/mdr541","journal-title":"Ann Oncol"},{"key":"1873_CR5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cgh.2009.06.008","volume":"7","author":"RE Brand","year":"2009","unstructured":"Brand RE et al (2009) Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clin Gastroenterol Hepatol 7:1007\u20131012. doi: 10.1016\/j.cgh.2009.06.008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1873_CR6","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403\u20132413","journal-title":"J Clin Oncol"},{"key":"1873_CR7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817\u20131825. doi: 10.1056\/NEJMoa1011923","journal-title":"N Engl J Med"},{"key":"1873_CR8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2010.10.015","volume":"9","author":"GA Cote","year":"2011","unstructured":"Cote GA et al (2011) Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 9:266\u2013273. doi: 10.1016\/j.cgh.2010.10.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1873_CR9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/MPA.0b013e318215a9b1","volume":"40","author":"M Dandona","year":"2011","unstructured":"Dandona M, Linehan D, Hawkins W, Strasberg S, Gao F, Wang-Gillam A (2011) Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer. Pancreas 40:931\u2013937. doi: 10.1097\/MPA.0b013e318215a9b1","journal-title":"Pancreas"},{"key":"1873_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000315731","volume":"78","author":"M Faehling","year":"2010","unstructured":"Faehling M, Eckert R, Kuom S, Kamp T, Stoiber KM, Schumann C (2010) Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line. Oncology 78:249\u2013258. doi: 10.1159\/000315731","journal-title":"Oncology"},{"key":"1873_CR11","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","volume":"20","author":"H Ijichi","year":"2006","unstructured":"Ijichi H et al (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 20:3147\u20133160. doi: 10.1101\/gad.1475506","journal-title":"Genes Dev"},{"key":"1873_CR12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/annonc\/mdp008","volume":"20","author":"M Kanai","year":"2009","unstructured":"Kanai M et al (2009) A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia. Ann Oncol 20:1397\u20131401. doi: 10.1093\/annonc\/mdp008","journal-title":"Ann Oncol"},{"key":"1873_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1634\/theoncologist.2012-0335","volume":"19","author":"D Keizman","year":"2014","unstructured":"Keizman D et al (2014) Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib. Oncologist 19:51\u201360. doi: 10.1634\/theoncologist.2012-0335","journal-title":"Oncologist"},{"key":"1873_CR14","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1158\/0008-5472.CAN-08-0851","volume":"68","author":"AY Khakoo","year":"2008","unstructured":"Khakoo AY, Sidman RL, Pasqualini R, Arap W (2008) Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis? Cancer Res 68:9112\u20139115. doi: 10.1158\/0008-5472.CAN-08-0851","journal-title":"Cancer Res"},{"key":"1873_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000337979","volume":"83","author":"ST Kim","year":"2012","unstructured":"Kim ST, Park KH, Oh SC, Seo JH, Kim JS, Shin SW, Kim YH (2012) How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy? Oncology 83:354\u2013360. doi: 10.1159\/000337979","journal-title":"Oncology"},{"key":"1873_CR16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/gast.2003.50147","volume":"124","author":"A Kuno","year":"2003","unstructured":"Kuno A et al (2003) Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn\/Kobori rats. Gastroenterology 124:1010\u20131019. doi: 10.1053\/gast.2003.50147","journal-title":"Gastroenterology"},{"key":"1873_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/00365521.2013.777776","volume":"48","author":"A Masamune","year":"2013","unstructured":"Masamune A, Hamada S, Kikuta K, Takikawa T, Miura S, Nakano E, Shimosegawa T (2013) The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Scand J Gastroenterol 48:602\u2013609. doi: 10.3109\/00365521.2013.777776","journal-title":"Scand J Gastroenterol"},{"key":"1873_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00006676-200401000-00006","volume":"28","author":"H Miyamoto","year":"2004","unstructured":"Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S (2004) Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 28:38\u201344","journal-title":"Pancreas"},{"key":"1873_CR19","doi-asserted-by":"crossref","unstructured":"Mizuno S et al (2014) Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients. Pancreas 43:1014\u20131017. doi: 10.1097\/mpa.0000000000000158","DOI":"10.1097\/MPA.0000000000000158"},{"key":"1873_CR20","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960\u20131966. doi: 10.1200\/JCO.2006.07.9525","journal-title":"J Clin Oncol"},{"key":"1873_CR21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000259616","volume":"77","author":"Y Nakai","year":"2009","unstructured":"Nakai Y et al (2009) A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer. Oncology 77:300\u2013303. doi: 10.1159\/000259616","journal-title":"Oncology"},{"key":"1873_CR22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","volume":"103","author":"Y Nakai","year":"2010","unstructured":"Nakai Y et al (2010) Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer 103:1644\u20131648. doi: 10.1038\/sj.bjc.6605955","journal-title":"Br J Cancer"},{"key":"1873_CR23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1349-7006.2012.02311.x","volume":"103","author":"Y Nakai","year":"2012","unstructured":"Nakai Y et al (2012a) Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1. Cancer Sci 103:1489\u20131492. doi: 10.1111\/j.1349-7006.2012.02311.x","journal-title":"Cancer Sci"},{"key":"1873_CR24","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/bjc.2012.183","volume":"106","author":"Y Nakai","year":"2012","unstructured":"Nakai Y et al (2012b) A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study. Br J Cancer 106:1934\u20131939. doi: 10.1038\/bjc.2012.183","journal-title":"Br J Cancer"},{"key":"1873_CR25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10637-013-9972-5","volume":"31","author":"Y Nakai","year":"2013","unstructured":"Nakai Y et al (2013) A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. Invest New Drugs 31:1294\u20131299. doi: 10.1007\/s10637-013-9972-5","journal-title":"Invest New Drugs"},{"key":"1873_CR26","doi-asserted-by":"crossref","unstructured":"Nakai Y et al (2014) A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer. Cancer Chemother Pharmacol 74:911\u2013915. doi: 10.1007\/s00280-014-2563-0","DOI":"10.1007\/s00280-014-2563-0"},{"key":"1873_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1349-7006.2010.01810.x","volume":"102","author":"T Okusaka","year":"2011","unstructured":"Okusaka T et al (2011) Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer. Cancer Sci 102:425\u2013431. doi: 10.1111\/j.1349-7006.2010.01810.x","journal-title":"Cancer Sci"},{"key":"1873_CR28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1126\/science.1175940","volume":"324","author":"P Olson","year":"2009","unstructured":"Olson P, Hanahan D (2009) Cancer. Breaching the cancer fortress. Science (New York, NY) 324:1400\u20131401. doi: 10.1126\/science.1175940","journal-title":"Science (New York, NY)"},{"key":"1873_CR29","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/ijc.25240","volume":"127","author":"SH Olson","year":"2010","unstructured":"Olson SH et al (2010) Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 127:2412\u20132419. doi: 10.1002\/ijc.25240","journal-title":"Int J Cancer"},{"key":"1873_CR30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000355107","volume":"85","author":"M O\u2019Malley","year":"2013","unstructured":"O\u2019Malley M, Healy P, Daignault S, Ramnath N (2013) Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors. Oncology 85:216\u2013222. doi: 10.1159\/000355107","journal-title":"Oncology"},{"key":"1873_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MPA.0b013e3182a7c74b","volume":"43","author":"C Pelucchi","year":"2014","unstructured":"Pelucchi C et al (2014) Smoking and body mass index and survival in pancreatic cancer patients. Pancreas 43:47\u201352. doi: 10.1097\/MPA.0b013e3182a7c74b","journal-title":"Pancreas"},{"key":"1873_CR32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00535-008-2249-7","volume":"43","author":"K Shimizu","year":"2008","unstructured":"Shimizu K (2008) Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 43:823\u2013832. doi: 10.1007\/s00535-008-2249-7","journal-title":"J Gastroenterol"},{"key":"1873_CR33","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/cncr.21884","volume":"106","author":"AS Tsao","year":"2006","unstructured":"Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK (2006) Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 106:2428\u20132436. doi: 10.1002\/cncr.21884","journal-title":"Cancer"},{"key":"1873_CR34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/ajg.2011.43","volume":"106","author":"EJ Geenen van","year":"2011","unstructured":"van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ (2011) Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol 106:1161\u20131166. doi: 10.1038\/ajg.2011.43","journal-title":"Am J Gastroenterol"},{"key":"1873_CR35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1517\/14712590903081694","volume":"9","author":"B Vincenzi","year":"2009","unstructured":"Vincenzi B et al (2009) Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients. Expert Opin Biol Ther 9:945\u2013949. doi: 10.1517\/14712590903081694","journal-title":"Expert Opin Biol Ther"},{"key":"1873_CR36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Hoff Von","year":"2013","unstructured":"Von Hoff DD et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691\u20131703. doi: 10.1056\/NEJMoa1304369","journal-title":"N Engl J Med"},{"key":"1873_CR37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00432-009-0587-3","volume":"135","author":"S Wilop","year":"2009","unstructured":"Wilop S, von Hobe S, Crysandt M, Esser A, Osieka R, Jost E (2009) Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy. J Cancer Res Clin Oncol 135:1429\u20131435. doi: 10.1007\/s00432-009-0587-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"1873_CR38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archinternmed.2009.125","volume":"169","author":"D Yadav","year":"2009","unstructured":"Yadav D et al (2009) Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 169:1035\u20131045. doi: 10.1001\/archinternmed.2009.125","journal-title":"Arch Intern Med"},{"key":"1873_CR39","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1245\/s10434-012-2568-z","volume":"19","author":"K Yuge","year":"2012","unstructured":"Yuge K, Miyajima A, Tanaka N, Shirotake S, Kosaka T, Kikuchi E, Oya M (2012) Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer. Ann Surg Oncol 19:3987\u20133993. doi: 10.1245\/s10434-012-2568-z","journal-title":"Ann Surg Oncol"},{"key":"1873_CR40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2013.08.014","volume":"50","author":"L Zou","year":"2014","unstructured":"Zou L et al (2014) Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: evidence from a meta-analysis of 42 observational studies. Eur J Cancer 50:193\u2013203. doi: 10.1016\/j.ejca.2013.08.014","journal-title":"Eur J Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1873-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1873-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T09:57:55Z","timestamp":1566035875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1873-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1873-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}